Medical Second Opinion Global Market to Register Stunning Growth at a CAGR of ~17% by 2028 | DelveInsight
The medical second opinion market is expanding rapidly due to the increasing frequency of malignancies, infectious diseases, genetic diseases, cardiovascular diseases, hematological diseases, orthopedic diseases, and other diseases around the world. The growing frequency of chronic diseases will increase the global patient pool, necessitating the need for a medical second opinion in the market
LAS VEGAS, Aug. 21, 2023 /PRNewswire/ -- DelveInsight's Medical Second Opinion Market Insights report provides the current and forecast market analysis, individual leading medical second opinion companies' market shares, challenges, medical second opinion market drivers, barriers, trends, and key market medical second opinion companies in the market.
Key Takeaways from the Medical Second Opinion Market Report
- As per DelveInsight estimates, North America is anticipated to dominate the global medical second opinion market during the forecast period.
- Notable medical second opinion companies such as Second Opinion International, EMS, 2nd.MD, WorldCare, MediGuide International, LLC., AXA, Cleveland Clinic., USARAD Holdings, Inc., a Nanox company, London Pain Clinic, Johns Hopkins University, Kauvery Hospital, Yashoda Hospitals., Vidal health insurance tpa pvt ltd., FOREIGN OPD, SecondMedic, and several others, are currently operating in the medical second opinion market.
- In January 2022, Apollo Hospitals Group collaborated with "The Clinic" by Cleveland Clinic, to bring international second opinion services to their patients.
To read more about the latest highlights related to the medical second opinion market, get a snapshot of the key highlights entailed in the Global Medical Second Opinion Market Report
Medical Second Opinion Overview
A medical second opinion is a valuable resource that empowers patients to make informed decisions about their health. It involves seeking input from another qualified medical professional, usually a specialist, to review a diagnosis, treatment plan, or proposed procedure. This process offers patients a fresh perspective, potentially uncovering alternative options or confirming the initial recommendation. Medical second opinions are particularly beneficial for complex or serious conditions, providing patients with greater confidence and understanding to navigate their healthcare journey. By promoting collaboration and thorough consideration of options, a medical second opinion ensures that patients are actively involved in their care and well-being.
Medical Second Opinion Market Insights
North America led the global medical second opinion market in 2021 and will continue to do so during the forecast period of 2023–2028. This might be attributed to the growing need for medical second views among patients in the region as a result of the rising prevalence of diseases such as cancer, cardiovascular disease, diabetes, infectious disease, and others. The rising burden of senior people prone to chronic diseases, increased demand for a virtual medical second opinion, and other factors are among the key factors driving the growth of the medical second opinion market in North America between 2023 and 2028.
To know more about why North America is leading the market growth in the medical second opinion market, get a snapshot of the Medical Second Opinion Market Outlook
Medical Second Opinion Market Dynamics
The growing global burden of cancer, cardiovascular diseases, hematologic blood disorders, orthopedic disorders, infectious diseases, and genetic diseases is propelling the medical second opinion market. The rising prevalence of hematological disorders including sickle cell anemia, thalassemia, and others has a beneficial impact on the medical second opinion industry. Furthermore, rising healthcare costs will increase demand for medical second views around the world, since it is employed as a cost-cutting measure. Moreover, the second medical opinion market is being pushed by a growing emphasis on avoiding extra expenses and increased awareness about potential exploitation by healthcare organizations, particularly in low- and middle-income nations.
However, factors such as a lack of understanding of medical second opinions, greater costs for medical second opinions, and others may stymie the medical second opinions market growth.
Additionally, during the COVID-19 pandemic, the medical second opinion market was positively impacted. During the early stages of the pandemic, the need for physical medical second opinions declined due to fewer visits by patients to hospitals or clinics for disease treatment or diagnosis as a result of severe lockdown measures imposed around the world. However, as the demand for virtual medical second opinions grew throughout the epidemic, the demand for medical second views grew rapidly. Patients loved the virtual method of medical second opinion service because they could have a consultation at their leisure and without putting their lives in danger. Similarly, the flexibility in lockdown restrictions, the administration of a vaccine to the public, the resumption of patients to clinics and hospitals second opinions, and the increasing demand for a virtual medical second opinion increased and is expected to grow during the forecast period.
Get a sneak peek at the medical second opinion market dynamics @ Medical Second Opinion Market Dynamics Analysis
Report Metrics | Details |
Coverage | Global |
Study Period | 2020–2028 |
Medical Second Opinion Market CAGR | ~17% |
Key Medical Second Opinion Companies | Second Opinion International, EMS, 2nd.MD, WorldCare, MediGuide International, LLC., AXA, Cleveland Clinic., USARAD Holdings, Inc., a Nanox company, London Pain Clinic, Johns Hopkins University, Kauvery Hospital, Yashoda Hospitals., Vidal health insurance tpa pvt ltd., FOREIGN OPD, SecondMedic, among others |
Medical Second Opinion Market Assessment
- Medical Second Opinion Market Segmentation
- Medical Second Opinion Market Segmentation By Disorder Type: Organ Transplant, Cardiac Disorder, Hematologic Blood Disorders, Orthopedic Disorders, Cancer, and Others
- Medical Second Opinion Market Segmentation By Service Provider: Hospitals, Health Insurance Companies, Online Services, and Others
- Medical Second Opinion Market Segmentation By Geography: North America, Europe, Asia-Pacific, and Rest of World
- Porter's Five Forces Analysis, Product Profiles, Case Studies, KOL's Views, Analyst's View
Which MedTech key players in the medical second opinion market are set to emerge as the trendsetter explore @ Medical Second Opinion Companies
Table of Contents
1 | Report Introduction |
2 | Executive summary |
3 | Regulatory and Patent Analysis |
4 | Key Factors Analysis |
5 | Porter's Five Forces Analysis |
6 | COVID-19 Impact Analysis on Medical Second Opinion Market |
7 | Medical Second Opinion Market Layout |
8 | Global Company Share Analysis – Key 3-5 Companies |
9 | Medical Second Opinion Market Company and Product Profiles |
10 | Project Approach |
11 | About DelveInsight |
Interested in knowing the medical second opinion market by 2028? Click to get a snapshot of the Medical Second Opinion Market Trends
Related Reports
Hemophilia Pipeline Insight – 2023 report provides comprehensive insights about the pipeline landscape, pipeline drug profiles, including clinical and non-clinical stage products, and the key Hemophilia companies, including Intellia tx, Amarna therapeutics, Expressi Ontherapeutics, GC Pharma, Chameleon Biosciences, Pfizer, UBI Pharma, GeneVentiv, Chia Tai Tianqing Pharmaceutical Group, Bayer, ASC Therapeutics, Catalyst Biosciences, Staidson Beijing BioPharmaceuticals, Spark Therapeutics, CSL Behring, Sanofi, Novo Nordisk, Centessa Pharmaceuticals, OPKO Health, among others.
Bladder Cancer Pipeline Insight – 2023 report provides comprehensive insights about the pipeline landscape, pipeline drug profiles, including clinical and non-clinical stage products, and the key bladder cancer companies, including CG Oncology, FKD Therapies, Bristol-Myers Squibb, LintonPharm Co., Ltd., ImmunityBio, Inc., Hamlet Pharma AB, Asieris Pharmaceuticals, Pfizer, Taizhou Hanzhong biomedical co. LTD, Protara Therapeutics, CicloMed LLC, enGene, Inc., Emtora Biosciences, Theralase Inc., Vaxiion Therapeutics, Janssen Research & Development, LLC, Astellas Pharma, RemeGen Co., Ltd., UroGen Pharma Ltd., Flame Biosciences, Aura Biosciences, BeiGene, Incyte Corporation, QED Therapeutics, G1 Therapeutics, AN0025, Kyowa Kirin, Inc., Infinity Pharmaceuticals, Shanghai Hengrui Pharmaceutical Co., Ltd., HiberCell, Inc., Ikena Oncology, Genentech, Fusion Pharmaceuticals, GI Innovation,SOTIO Biotech AG, Celon Pharma SA, 4D Pharma PLC, Keythera Pharmaceuticals, Quadriga Biosciences, Inc., NeoTX Therapeutics Ltd., Mirati Therapeutics, NGM Biopharmaceuticals, TransThera Biosciences, Ocellaris Pharma, Palleon Pharmaceuticals, Medicenna Therapeutics, Klus Pharma, Novartis, Toray Industries, Carisma Therapeutics, Avacta Life Sciences Ltd, Seagen Inc., Elevation Oncology, Corvus Pharmaceuticals, ADC Therapeutics S.A., IO Biotech, Byondis B.V., Takara Bio, Seven and Eight Biopharmaceuticals, Dragonfly Therapeutics, InnoCare Pharma, among others.
Acute Ischemic Stroke Market Insight, Epidemiology, and Market Forecast – 2032 report delivers an in-depth understanding of the market trends, market drivers, market barriers, and key acute ischemic stroke companies, including Acticor Biotech, DiaMedica Therapeutics, Lumosa Therapeutics, Bristol Myers Squibb, Janssen Pharmaceutical, Genentech, Inc., Athersy, Healios K.K., NoNO Inc., Bayer, ZZ Biotech, Biogen Inc., Revalesio Corporation, AbbVie, TrueBinding, Inc, Silver Creek Pharmaceuticals, among others.
Alzheimer's Disease Market Insights, Epidemiology, and Market Forecast – 2032 report deliver an in-depth understanding of the disease, historical and forecasted epidemiology, as well as the market trends, market drivers, market barriers, and key Alzheimer's disease companies including Biogen, AZTherapies, Cerecin, Neurotrope, Synaptogenix, INmune Bio, Cassava Sciences, EIP Pharma, Neuraly, AB Science, Cortexyme, Anavex Life Sciences, Athira Pharma, Time Therapeutics, Denali Therapeutics Inc., Alector Inc., Lexeo Therapeutics, TrueBinding, Inc., Vaccinex Inc., Annovis Bio Inc., Eisai Inc., Hoffmann-La Roche, Ionis Pharmaceuticals, Inc., Otsuka Pharmaceutical Co., Ltd., Cognition Therapeutics, Merck Sharp & Dohme LLC, ImmunoBrain Checkpoint, AbbVie, AriBio Co., Ltd., Oryzon Genomics S.A., Eli Lilly and Company, Neurokine Therapeutics, Excelsior, Seelos Therapeutics, Inc., Janssen Research & Development, LLC, Shanghai Hengrui Pharmaceutical Co., Ltd., reMYND, Alzinova AB, VTBIO Co. LTD, BioVie Inc., Prothena Corporation plc, Coya Therapeutics, Inc., among others.
About DelveInsight
DelveInsight is a leading Business Consultant, and Market Research firm focused exclusively on life sciences. It supports pharma companies by providing comprehensive end-to-end solutions to improve their performance.
Contact Us
Shruti Thakur
[email protected]
+1(919)321-6187
https://www.delveinsight.com/medical-devices
Logo: https://mma.prnewswire.com/media/1082265/3528414/DelveInsight_Logo.jpg
SOURCE DelveInsight Business Research, LLP
Share this article